Viking Therapeutics Inc (VKTX)
33.12
-1.87%
Viking Therapeutics Inc (VKTX) is currently trading at $33.12. This represents a loss of 1.87% from the previous session. With a market capitalization of $3.83B, VKTX is a key component of the Health Care sector. Investors looking to trade VKTX should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Claim Your $300 Cash Bonus →
T&Cs Apply. Trade VKTX commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Viking Therapeutics Inc (VKTX) shows a bearish trend. Analysts are watching the 34.38 level closely.
Fundamentals
Mkt Cap3.83B
P/E Ratio0.0000
Volume0
60-Day Technical Chart
Advanced Charting
Need more indicators for VKTX? Use the world's #1 platform.
Open VKTX on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $33
| Metric |
VKTX -1.87% |
WOW +2.02% |
FIBK -0.83% |
ALCO +0.20% |
|---|---|---|---|---|
| Price | $33.12 | $36.35 | $30.99 | $35.21 |
| Mkt Cap | $3.83B | $44.45B | $3.21B | $0.27B |
| - | View → | View → | View → |
Latest Headlines
Viking Therapeutics Stock Jumps 11% After Obesity Drug Update: Analysts See $93 Target
TIKR.com • Feb 24, 2026
$VKTX stock is up 12% today. Here's what we see in our data.
Quiver Quantitative • Feb 23, 2026
Viking Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Corporate Update
PR Newswire • Feb 11, 2026
Viking Therapeutics: Full-Speed Ahead (NASDAQ:VKTX)
Seeking Alpha • Feb 14, 2026
Is Viking Therapeutics (VKTX) Offering Value After Recent Share Price Weakness
Yahoo Finance • Feb 4, 2026
● Gemini Agentic AI Analyst Insight for VKTX
Market Education
- From Small Players to Market Movers: How Former Small Caps Are Scaling Up Sep 27, 2025
- Government Shutdowns: What They Mean for Wall Street Sep 26, 2025
- That suit said read and analyze Market trends. How ? Jul 18, 2023
External Research